Comorbidity of Physical Disorders Among Patients With Severe Mental Illness With and Without Substance Use Disorders: A Systematic Review and Meta-Analysis

Journal of Dual Diagnosis

Volumn 15, Issue 3, 2019, Pages 192-206

  Onyeka, Ifeoma N ^a,b   Collier Høegh, Margrethe ^a   Nåheim Eien, Eldbjørg Marie ^a   Nwaru, Bright I ^c   Melle, Ingrid ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

bipolar disorder; Comorbidity; physical disorders; psychotic disorders; schizophrenia; severe mental illness; substance use disorders

Indexed keywords

BIPOLAR DISORDER; CARDIOVASCULAR DISEASE; COMORBIDITY; DATA BASE; DEATH; DIABETES MELLITUS; DRUG DEPENDENCE; EAR DISEASE; ENDOCRINE DISEASE; EYE DISEASE; GASTROINTESTINAL DISEASE; HEPATITIS C; HUMAN; HYPERTENSION; MALIGNANT NEOPLASM; MENTAL DISEASE; META ANALYSIS; MUSCULOSKELETAL DISEASE; NEUROLOGIC DISEASE; PHYSICAL DISEASE; PREVALENCE; PSYCHOSIS; RESPIRATORY TRACT DISEASE; REVIEW; SCHIZOPHRENIA; SKIN DISEASE; SYSTEMATIC REVIEW; TARDIVE DYSKINESIA; UROGENITAL TRACT DISEASE; VIRUS INFECTION; WORLD HEALTH ORGANIZATION; WOUND; DISEASES; EPIDEMIOLOGY; PSYCHOLOGY;

COMORBIDITY; DISEASE; EPIDEMIOLOGY; HUMANS; MENTAL DISORDERS; SUBSTANCE-RELATED DISORDERS;

EID: 85071274818     PISSN: 15504263     EISSN: 15504271     Source Type: Journal    
DOI: 10.1080/15504263.2019.1619007     Document Type: Review

References (66)

1. Amann, B. L., Radua, J., Wunsch, C., König, B., & Simhandl, C. (2017). Psychiatric and physical comorbidities and their impact on the course of bipolar disorder: A prospective, naturalistic 4-year follow-up study. Bipolar Disorders, 19(3), 225–234. doi:10.1111/bdi.12495
2. Ayerbe, L., Forgnone, I., Addo, J., Siguero, A., Gelati, S., & Ayis, S. (2018). Hypertension risk and clinical care in patients with bipolar disorder or schizophrenia: A systematic review and meta-analysis. Journal of Affective Disorders, 225, 665–670. doi:10.1016/j.jad.2017.09.002
3. Bailey, L., Maxwell, S., & Brandabur, M. M. (1997). Substance abuse as a risk factor for tardive dyskinesia: A retrospective analysis of 1,027 patients. Psychopharmacology Bulletin, 33(1), 177–781.
4. Birkenaes, A. B., Opjordsmoen, S., Brunborg, C., Engh, J. A., Jonsdottir, H., Ringen, P. A., … Andreassen, O. A. (2007). The level of cardiovascular risk factors in bipolar disorder equals that of schizophrenia: A comparative study. The Journal of Clinical Psychiatry, 68(6), 917–923. doi:10.4088/JCP.v68n0614
5. Borenstein, M., Hedges, L. V., Higgins, J. P. T., & Rothstein, H. R. (2010). A basic introduction to fixed-effect and random-effects models for meta-analysis. Research Synthesis Methods, 1(2), 97–111. doi:10.1002/jrsm.12
6. Borenstein, M., Hedges, L., Higgins, J., & Rothstein, H. (2005). Comprehensive Meta-Analysis Version 3. [Computer software]. Englewood, NJ: Biostat.
7. Bruckner, T. A., Yoon, J., & Gonzales, M. (2017). Cardiovascular disease mortality of Medicaid clients with severe mental illness and a co-occurring substance use disorder. Administration and Policy in Mental Health and Mental Health Services Research, 44(2), 284–292. doi:10.1007/s10488-016-0722-9
8. Buckley, P. F. (2006). Prevalence and consequences of the dual diagnosis of substance abuse and severe mental illness. Journal of Clinical Psychiatry, 67(Suppl 7), 5–9.
9. Butterfield, M. I., Bosworth, H. B., Meador, K. G., Stechuchak, K. M., Essock, S. M., Osher, F. C., … Horner, R. D. (2003). Gender differences in hepatitis C infection and risks among persons with severe mental illness. Psychiatric Services, 54(6), 848–853. doi:10.1176/appi.ps.54.6.848
10. Cornett, E. M., Novitch, M., Kaye, A. D., Kata, V., & Kaye, A. M. (2017). Medication-induced tardive dyskinesia: A review and update. Ochsner Journal, 17(2), 162–174.
11. De Hert, M., Dekker, J. M., Wood, D., Kahl, K. G., Holt, R. I., & Möller, H. J. (2009). Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC). European Psychiatry, 24(6), 412–424. doi:10.1016/j.eurpsy.2009.01.005
12. De Hert, M., Vancamfort, D., & Deraux, J. (2015). Somatic problems and dual disorder patients. In: Dom, G., & Moggi, F. (Eds.), Co-occurring addictive and psychiatric disorders: A practice-based handbook from a European perspective, (pp.349–361). Heidelberg, Germany: Springer. doi:10.1007/978-3-642-45375-5_23
13. Deady, M., Teeson, M., & Brady, K. T. (2013). Impact of substance use on the course of serious mental disorders. Principles of Addiction, (pp. 525–532). London, UK: Academic Press.
14. Dickerson, F., Adamos, M. B., Katsafanas, E., Khushalani, S., Origoni, A., Savage, C. L. G., … Yolken, R. (2016). The association among smoking, HSV-1 exposure, and cognitive functioning in schizophrenia, bipolar disorder, and non-psychiatric controls. Schizophrenia Research, 176(2–3), 566–571. doi:10.1016/j.schres.2016.05.022
15. Dickey, B., Azeni, H., Weiss, R., & Sederer, L. (2000). Schizophrenia, substance use disorders, and medical comorbidity. The Journal of Mental Health Policy and Economics, 3(1), 27–33.
16. Dickey, B., Normand, S. T., Weiss, R. D., Drake, R. E., & Azeni, H. (2002). Medical morbidity, mental illness, and substance use disorders. Psychiatric Services, 53(7), 861–867. doi:10.1176/appi.ps.53.7.861
17. Dixon, L., Weiden, P. J., Haas, G., Sweeney, J., & Frances, A. J. (1992). Increased tardive dyskinesia in alcohol-abusing schizophrenic patients. Comprehensive Psychiatry, 33(2), 121–122. doi:10.1016/0010-440X(92)90008-E
18. Duke, P. J., Pantelis, C., & Barnes, T. R. (1994). South Westminster Schizophrenia Survey: Alcohol use and its relationship to symptoms, tardive dyskinesia and illness onset. British Journal of Psychiatry, 164(5), 630–636. doi:10.1192/bjp.164.5.630
19. Duko, B., Ayano, G., Bekana, L., & Assefa, D. (2015). Prevalence and correlates of co-occurring substance use disorder among patients with severe mental disorder at Amanuel Mental Specialized Hospital, Addis Ababa, Ethiopia. Journal of Neuropsychopharmacology and Mental Health, 1(1), 101. doi:10.4172/2472-095X.1000101
20. Essock, S. M., Dowden, S., Constantine, N. T., Katz, L., Swartz, M. S., Meador, K. G., … Rosenberg, S. D. (2003). Blood-borne infections and persons with mental illness: Risk factors for HIV, hepatitis B, and hepatitis C among persons with severe mental illness. Psychiatric Services, 54(6), 836–841. doi:10.1176/appi.ps.54.6.836
21. Fan, Z., Wu, Y., Shen, J., Ji, T., & Zhan, R. (2013). Schizophrenia and the risk of cardiovascular diseases: A meta-analysis of thirteen cohort studies. Journal of Psychiatric Research, 47(11), 1549–1556. doi:10.1016/j.jpsychires.2013.07.011
22. Fleischhacker, W. W., Cetkovich-Bakmas, M., De Hert, M., Hennekens, C. H., Lambert, M., Leucht, S., … Lieberman, J. A. (2008). Comorbid somatic illnesses in patients with severe mental disorders: Clinical, policy, and research challenges. The Journal of Clinical Psychiatry, 69(4), 514–519. doi:10.4088/JCP.v69n0401
23. Frasch, K., Larsen, J. I., Cordes, J., Jacobsen, B., Wallenstein Jensen, S. O., Lauber, C., … Becker, T. (2013). Physical illness in psychiatric inpatients: Comparison of patients with and without substance use disorders. International Journal of Social Psychiatry, 59(8), 757–764. doi:10.1177/0020764012456803
24. Frishman, W. H., Del Vecchio, A., Sanal, S., & Ismail, A. (2003a). Cardiovascular manifestations of substance abuse part 1: Cocaine. Heart Disease, 5(3), 187–201. doi:10.1097/01.hdx.0000074519.43281.fa
25. Frishman, W. H., Del Vecchio, A., Sanal, S., & Ismail, A. (2003b). Cardiovascular manifestations of substance abuse part 2: Alcohol, amphetamines, heroin, cannabis, and caffeine. Heart Disease, 5(4), 253–271. doi:10.1097/01.hdx.0000080713.09303.a6
26. Fuller, B. E., Rodriguez, V. L., Linke, A., Sikirica, M., Dirani, R., & Hauser, P. (2011). Prevalence of liver disease in veterans with bipolar disorder or schizophrenia. General Hospital Psychiatry, 33(3), 232–237. doi:10.1016/j.genhosppsych.2011.03.006
27. Garcia-Portilla, M. P., Saiz, P. A., Benabarre, A., Florez, G., Bascaran, M. T., Díaz, E. M., … Bobes, J. (2009). Impact of substance use on the physical health of patients with bipolar disorder. Acta Psychiatrica Scandinavica, 121(6), 437–445. doi:10.1111/j.1600-0447.2009.01498.x
28. Gordon, A. J. (2010). Physical illness and drugs of abuse: A review of the evidence (p. 5–6). Cambridge, UK: Cambridge University Press.
29. Hansen, L. K., Nausheen, B., Hart, D., & Kingdon, D. (2013). Movement disorders in patients with schizophrenia and a history of substance abuse. Human Psychopharmacology: Clinical and Experimental, 28(2), 192–197. doi:10.1002/hup.2305
30. Helleberg, M., Pedersen, M. G., Pedersen, C. B., Mortensen, P. B., & Obel, N. (2015). Associations between HIV and schizophrenia and their effect on HIV treatment outcomes: A nationwide population-based cohort study in Denmark. Lancet HIV, 2(8), e344–e350. doi:10.1016/S2352-3018(15)00089-2
31. Higgins, J. P. T., & Green, S. (2008). Cochrane handbook for systematic reviews of interventions (p. 285). Hoboken, NJ: Wiley-Blackwell.
32. Higgins, J. P., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003). Measuring inconsistency in meta-analyses. BMJ, 327(7414), 557–560. doi:10.1136/bmj.327.7414.557
33. Hjorthøj, C., Østergaard, M. L., Benros, M. E., Toftdahl, N. G., Erlangsen, A., Andersen, J. T., & Nordentoft, M. (2015). Association between alcohol and substance use disorders and all-cause and cause-specific mortality in schizophrenia, bipolar disorder, and unipolar depression: A nationwide, prospective, register-based study. Lancet Psychiatry, 2(9), 801–808. doi:10.1016/S2215-0366(15)00207-2
34. Holt, R. I. (2012). Cardiovascular disease and diabetes in people with severe mental illness: Causes, consequences and pragmatic management. South African Journal of Diabetes and Vascular Disease, 9(3), 107–111.
35. Huckans, M. S., Blackwell, A. D., Harms, T. A., & Hauser, P. (2006). Management of hepatitis C disease among VA patients with schizophrenia and substance use disorders. Psychiatric Services, 57(3), 403–406. doi:10.1176/appi.ps.57.3.403
36. Icick, R., Gard, S., Barde, M., Carminati, M., Desage, A., Guillaume, S., … Bellivier, F. (2017). Physical and mental health burden in cases of bipolar disorder classified as current, former, or non-tobacco smokers. Journal of Affective Disorders, 208, 406–413. doi:10.1016/j.jad.2016.09.022
37. Jones, D. R., Macias, C., Barreira, P. J., Fisher, W. H., Hargreaves, W. A., & Harding, C. M. (2004). Prevalence, severity, and co-occurrence of chronic physical health problems of persons with serious mental illness. Psychiatric Services, 55(11), 1250–1257. doi:10.1176/appi.ps.55.11.1250
38. Jung, D. U., Kelly, D. L., Oh, M. K., Kong, B. G., Kang, J. W., Lee, S. J., & Shim, J. C. (2011). Bone mineral density and osteoporosis risk in older patients with schizophrenia. Journal of Clinical Psychopharmacology, 31(4), 406–410. doi:10.1097/JCP.0b013e318221b123
39. Kelly, D. L., Myers, C. S., Abrams, M. T., Feldman, S., Park, J., McMahon, R. P., & Shim, J. C. (2011a). The impact of substance abuse on osteoporosis screening and risk of osteoporosis in women with psychotic disorders. Osteoporosis International, 22(4), 1133–1143. doi:10.1007/s00198-010-1294-2
40. Kelly, D. L., McMahon, R. P., Wehring, H. J., Liu, F., Mackowick, K. M., Boggs, D. L., … Dixon, L. (2011b). Cigarette smoking and mortality risk in people with schizophrenia. Schizophrenia Bulletin, 37(4), 832–838. doi:10.1093/schbul/sbp152
41. Koola, M. M., McMahon, R. P., Wehring, H. J., Liu, F., Mackowick, K. M., Warren, K. R., … Kelly, D. L. (2012). Alcohol and cannabis use and mortality in people with schizophrenia and related psychotic disorders. Journal of Psychiatric Research, 46(8), 987–993. doi:10.1016/j.jpsychires.2012.04.019
42. Krishnan, K. R. (2005). Psychiatric and medical comorbidities of bipolar disorder. Psychosomatic Medicine, 67(1), 1–8. doi:10.1097/01.psy.0000151489.36347.18
43. Leucht, S., Burkard, T., Henderson, J., Maj, M., & Sartorius, N. (2007). Physical illness and schizophrenia: A review of the literature. Acta Psychiatrica Scandinavica, 116(5), 317–333. doi:10.1111/j.1600-0447.2007.01095.x
44. Lin, W. C., Zhang, J., Leung, G. Y., & Clark, R. E. (2011). Chronic physical conditions in older adults with mental illness and/or substance use disorders. Journal of the American Geriatrics Society, 59(10), 1913–1921. doi:10.1111/j.1532-5415.2011.03588.x
45. Matthews, A. M., Huckans, M. S., Blackwell, A. D., & Hauser, P. (2008). Hepatitis C testing and infection rates in bipolar patients with and without comorbid substance use disorders. Bipolar Disorders, 10(2), 266–270. doi:10.1111/j.1399-5618.2007.00472.x
46. McGinty, E. E., Baker, S. P., Steinwachs, D. M., & Daumit, G. (2013). Injury risk and severity in a sample of Maryland residents with serious mental illness. Injury Prevention, 19(1), 32–37. doi:10.1136/injuryprev-2011-040309
47. McIntyre, R. S., Soczynska, J. K., Beyer, J. L., Woldeyohannes, H. O., Law, C. W., Miranda, A., … Kennedy, S. H. (2007). Medical comorbidity in bipolar disorder: Re-prioritizing unmet needs. Current Opinion in Psychiatry, 20(4), 406–416. doi:10.1097/YCO.0b013e3281938102
48. Moher, D., Shamseer, L., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., … Stewart, L. A. (2015). Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Systematic Reviews, 4(1), 1–9. doi:10.1186/2046-4053-4-1
49. Nilsson, F. M., Kessing, L. V., & Bolwig, T. G. (2003). On the increased risk of developing late-onset epilepsy for patients with major affective disorder. Journal of Affective Disorder, 76(1–3), 39–48. doi:10.1016/S0165-0327(02)00061-7
50. Osborn, D. P. (2001). The poor physical health of people with mental illness. Western Journal of Medicine, 175(5), 329–332. doi:10.1136/ewjm.175.5.329
51. Osher, F. C., Goldberg, R. W., McNary, S. W., Swartz, M. S., Essock, S. M., Butterfield, M. I., & Rosenberg, S. D. (2003). Substance abuse and the transmission of hepatitis C among persons with severe mental illness. Psychiatric Services, 54(6), 842–847. doi:10.1176/appi.ps.54.6.842
52. Oud, M. J., & Meyboom-de Jong, B. (2009). Somatic diseases in patients with schizophrenia in general practice: Their prevalence and health care. BMC Family Practice, 10(32), 1–9. doi:10.1186/1471-2296-10-32
53. Prince, J. D., Walkup, J., Akincigil, A., Amin, S., & Crystal, S. (2012). Serious mental illness and risk of new HIV/AIDS diagnoses: An analysis of Medicaid beneficiaries in eight states. Psychiatric Services, 63(10), 1032–1038. doi:10.1176/appi.ps.201100342
54. Rado, J. (2017). Hepatitis C among the mentally ill: Review and treatment update. Current Psychiatry, 16(3), 41–47.
55. Rao, S., Raney, L., & Xiong, G. L. (2015). Reducing medical comorbidity and mortality in severe mental illness: Collaboration with primary and preventive care could improve outcomes. Current Psychiatry, 14(7), 15–20.
56. Ringen, P. A., Engh, J. A., Birkenaes, A. B., Dieset, I., & Andreassen, O. A. (2014). Increased mortality in schizophrenia due to cardiovascular disease–A non-systematic review of epidemiology, possible causes, and interventions. Frontiers in Psychiatry, 5(137), 1–11. doi:10.3389/fpsyt.2014.00137
57. Rosenberg, S. D., Drake, R. E., Brunette, M. F., Wolford, G. L., & Marsh, B. J. (2005). Hepatitis C virus and HIV co-infection in people with severe mental illness and substance use disorders. AIDS, 19(Suppl 3), s26–s33. doi:10.1097/01.aids.0000192067.94033.aa
58. Rosenberg, S. D., Goodman, L. A., Osher, F. C., Swartz, M. S., Essock, S. M., Butterfield, M. I., …… Salyers, M. P. (2001). Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness. American Journal of Public Health, 91(1), 31–37. doi:10.2105/ajph.91.1.31
59. Roshanaei-Moghaddam, B., & Katon, W. (2009). Premature mortality from general medical illnesses among persons with bipolar disorder: A review. Psychiatric Services, 60(2), 147–156. doi:10.1176/ps.2009.60.2.147
60. Shamseer, L., Moher, D., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., … Stewart, L. A. (2015). Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: Elaboration and explanation. BMJ, 349, 1–25. doi:10.1136/bmj.g7647
61. Šprah, L., Dernovšek, M. Z., Wahlbeck, K., & Haaramo, P. (2017). Psychiatric readmissions and their association with physical comorbidity: A systematic literature review. BMC Psychiatry, 17(2), 1–17. doi:10.1186/s12888-016-1172-3
62. Sylvia, L. G., Shelton, R. C., Kemp, D. E., Bernstein, E. E., Friedman, E. S., Brody, B. D., … Calabrese, J. R. (2015). Medical burden in bipolar disorder: Findings from the Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder study (Bipolar CHOICE). Bipolar Disorders, 17(2), 212–223. doi:10.1111/bdi.12243
63. Tang, H. C., Chen, P. H., Chung, K. H., Kuo, C. J., Huang, S. H., & Tsai, S. Y. (2015). Psychological outcomes and medical morbidity of patients with bipolar disorder and co-occurring alcohol use disorder. Journal of Dual Diagnosis, 11(3–4), 184–188. doi:10.1080/15504263.2015.1113099
64. Toftegaard, K. L., Gustafsson, L. N., Uwakwe, R., Andersen, U. A., Becker, T., Bickel, G. G., … Munk-Jørgensen, P. (2015). Where are patients who have co-occurring mental and physical diseases located? International Journal of Social Psychiatry, 61(5), 456–464. doi:10.1177/0020764014552866
65. Wildgust, H. J., & Beary, M. (2010). Are there modifiable risk factors which will reduce the excess mortality in schizophrenia? Journal of Psychopharmacology, 24(4_Suppl), 37–50. doi:10.1177/1359786810384639
66. Zhang, X. Y., Yu, Y. Q., Sun, S., Zhang, X., Li, W., Xiu, M. H., … Kosten, T. R. (2011). Smoking and tardive dyskinesia in male patients with chronic schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 35(7), 1765–1769. doi:10.1016/j.pnpbp.2011.06.006